NeuroSense Therapeutics Ltd.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

NRSN

organization

SIC: 2834

SEC Insider

$400K

5 transactions

Summary

NeuroSense Therapeutics Ltd. (NRSN) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $400KSales: —4 insiders

Date	Insider	Type	Value
2026-06-16	Eisenberg Or(Chief Financial Officer)	Buy	$200K
2026-06-16	Ben-Noon Alon(Chief Executive Officer)	Buy	$200K
2026-03-26	Binder Hagit(General Manager)	A	$0
2026-03-26	Russek-Blum Niva(Chief Technology Officer)	A	$0
2026-03-26	Eisenberg Or(Chief Financial Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

NeuroSense Therapeutics Ltd. — Contributions, Lobbying & Contracts | Poliscope